Bliss GVS Pharma Ltd.
| BSE: 506197 | Sector: Health care |
| NSE: BLISSGVS | ISIN Code: INE416D01022 |
| BSE 11:07 | 25 Feb | 175.20 |
-1.05 (-0.60%) |
OPEN
178.20 |
HIGH
178.20 |
LOW
174.70 |
| NSE 10:49 | 25 Feb | 174.65 |
-1.60 (-0.91%) |
OPEN
177.30 |
HIGH
177.65 |
LOW
174.60 |
| OPEN | 178.20 |
| PREVIOUS CLOSE | 176.25 |
| VOLUME | 214091 |
| 52-Week high | 224.00 |
| 52-Week low | 82.50 |
| P/E | 24.17 |
| Mkt Cap.(Rs cr) | 1,806 |
| Buy Price | 175.15 |
| Buy Qty | 28.00 |
| Sell Price | 175.20 |
| Sell Qty | 132.00 |
Bliss GVS Pharma Ltd. (BLISSGVS) - Announcements
-
Bliss GVS Pharma Ltd Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015
05/02/2021 | bse |
Downlaod PDF -
Bliss GVS Pharma Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication
25/01/2021 | bse |
Downlaod PDF -
Bliss GVS Pharma Ltd Outcome Of Board Meeting Held On Thursday January 21 2021
21/01/2021 | bse |
Downlaod PDF -
Bliss GVS Pharma Ltd Shareholding for the Period Ended December 31 2020
16/01/2021 | bse
-
Bliss GVS Pharma Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
15/01/2021 | bse |
Downlaod PDF -
Bliss GVS Pharma Ltd Statement Of Investor Complaints For The Quarter Ended December 2020
15/01/2021 | bse
-
Bliss GVS Pharma Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication
15/01/2021 | bse |
Downlaod PDF -
Bliss GVS Pharma Ltd Announcement under Regulation 30 (LODR)-Credit Rating
13/01/2021 | bse |
Downlaod PDF -
Bliss GVS Pharma Ltd Board Meeting Intimation for Unaudited Standalone & Consolidated Financial Results Of The Company Fo
13/01/2021 | bse |
Downlaod PDF -
Bliss GVS Pharma Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
04/01/2021 | bse |
Downlaod PDF -
Bliss GVS Pharma Ltd Closure of Trading Window
29/12/2020 | bse |
Downlaod PDF -
Bliss GVS Pharma Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
24/12/2020 | bse |
Downlaod PDF -
Bliss GVS Pharma Ltd Intimation About Approval Letters Received From BSE Limited And National Stock Exchange Of India Lim
15/12/2020 | bse |
Downlaod PDF -
Bliss GVS Pharma Ltd Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.
13/11/2020 | bse |
Downlaod PDF -
Bliss GVS Pharma Ltd Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.
13/11/2020 | bse |
Downlaod PDF -
Bliss GVS Pharma Ltd Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.
12/11/2020 | bse |
Downlaod PDF -
Bliss GVS Pharma Ltd Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.
12/11/2020 | bse |
Downlaod PDF -
Bliss GVS Pharma Ltd Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.
12/11/2020 | bse |
Downlaod PDF -
Bliss GVS Pharma Ltd Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange
05/11/2020 | bse |
Downlaod PDF -
Bliss GVS Pharma Ltd Certificate Under Regulation 40(9) Of The Securities And Exchange Board Of India (Listing Obligation
29/10/2020 | bse |
Downlaod PDF
Quick Links for Bliss GVS Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
